Maximilian J Waldner Selected Research

Cytokines

11/2019	Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.
4/2015	From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.
4/2012	Potential avenues for immunotherapy of colitis-associated neoplasia.
1/2012	Interleukin-6--a key regulator of colorectal cancer development.
4/2010	Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer.
12/2009	Novel cytokine-targeted therapies and intestinal inflammation.
7/2009	Colitis-associated cancer: the role of T cells in tumor development.
9/2008	Cytokines in colitis associated cancer: potential drug targets?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maximilian J Waldner Research Topics

Disease

19	Neoplasms (Cancer) 09/2023 - 09/2008
18	Inflammation (Inflammations) 09/2023 - 09/2008
16	Colitis 01/2024 - 09/2008
12	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 02/2010
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 12/2009
7	Colitis-Associated Neoplasms 01/2020 - 09/2008
5	Crohn Disease (Crohn's Disease) 01/2019 - 09/2011
4	Carcinogenesis 04/2015 - 09/2008
3	Ulcerative Colitis 09/2023 - 02/2014
3	Fibrosis (Cirrhosis) 09/2023 - 01/2019
2	Disease Progression 03/2024 - 12/2019
2	Necrosis 01/2019 - 09/2011
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2011 - 12/2010
2	Colonic Neoplasms (Colon Cancer) 09/2011 - 12/2010
1	Peripheral Arterial Disease 01/2023
1	Anemia 12/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2019
1	Muscular Diseases (Myopathy) 12/2019
1	Edema (Dropsy) 11/2019
1	Endotoxemia 03/2014
1	Intestinal Diseases (Diseases, Intestinal) 02/2014
1	Hepatocellular Carcinoma (Hepatoma) 12/2012
1	Brain Edema (Cerebral Edema) 04/2012
1	Brain Ischemia (Cerebral Ischemia) 04/2012
1	Hypoxia (Hypoxemia) 04/2010

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 11/2019 - 09/2008
7	Interleukin-6 (Interleukin 6)IBA 04/2015 - 09/2008
6	AntibodiesIBA 11/2019 - 02/2010
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024 - 09/2009
5	Dextrans (Dextran)FDA Link 01/2024 - 09/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 09/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2010
3	Interleukin-23 (Interleukin 23)IBA 01/2019 - 09/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 12/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 12/2022
2	OxazoloneIBA 11/2022 - 09/2009
2	Collagen Type VIIBA 03/2022 - 01/2019
2	CollagenIBA 12/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2012
2	Interleukin-12 (IL 12)IBA 08/2009 - 09/2008
1	tributyrinIBA 01/2024
1	Butyrates (Butyrate)IBA 01/2024
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2024
1	ProdrugsIBA 01/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 09/2023
1	RNA (Ribonucleic Acid)IBA 09/2023
1	OligonucleotidesIBA 09/2023
1	CarbohydratesIBA 09/2023
1	GlycosaminoglycansIBA 09/2023
1	SulfotransferasesIBA 09/2023
1	Cyclin-Dependent Kinase 4IBA 09/2023
1	palbociclibIBA 09/2023
1	Cyclin-Dependent Kinase Inhibitor p21IBA 09/2023
1	Dextran SulfateIBA 11/2022
1	Collagen Type I (Type I Collagen)IBA 03/2022
1	chlorinIBA 01/2020
1	cadherin 5IBA 11/2019
1	integrin alpha4beta7IBA 11/2019
1	Imatinib Mesylate (Gleevec)FDA Link 11/2019
1	IntegrinsIBA 11/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2019
1	InterleukinsIBA 01/2019
1	polyolIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Bevacizumab (Avastin)FDA Link 07/2015
1	AntigensIBA 03/2015
1	LipopolysaccharidesIBA 03/2014
1	Rho Guanine Nucleotide Exchange FactorsIBA 03/2014
1	EpiregulinIBA 04/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013
1	PanobinostatIBA 12/2012
1	Sorafenib (BAY 43-9006)FDA Link 12/2012
1	BradykininIBA 04/2012
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2012
1	Janus KinasesIBA 01/2012
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2011
1	Adalimumab (Humira)FDA Link 12/2011
1	Infliximab (Remicade)FDA Link 12/2011
1	Certolizumab Pegol FDA Link 12/2011
1	Caspase 8 (Caspase-8)IBA 09/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2010
1	Transcription Factors (Transcription Factor)IBA 04/2010
1	PerforinIBA 04/2010
1	Mitogen-Activated Protein KinasesIBA 04/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2010
1	AzoxymethaneIBA 04/2010

Therapy/Procedure

15	Therapeutics 03/2024 - 09/2008
4	Lasers (Laser) 01/2017 - 09/2011
3	Immunotherapy 09/2023 - 04/2012
1	Injections 01/2019
1	Aftercare (After-Treatment) 07/2015
1	Precision Medicine 03/2014
1	Endoscopes 09/2011